Skip to Main Content

Paper Details

Ataxia Telangiectasia Mutated Protein Loss and Benefit From Oxaliplatin-based Chemotherapy in Colorectal Cancer.
Clin Colorectal Cancer
30
2018
Author NameAffiliation
Susana MirandaThe Institute of Cancer Research
Matthew ClarkeThe Institute of Cancer Research
Wei YuanThe Institute of Cancer Research
Gunther BoysenThe Institute of Cancer Research
Nina TunariuThe Institute of Cancer Research, UK The Royal Marsden NHS Trust
Joaquin MateoThe Institute of Cancer Research
Suzanne CarreiraThe Institute of Cancer Research
Johann S de BonoThe Institute of Cancer Research, UK The Royal Marsden NHS Trust
  • 1 - 8

Datasets

Release 1.2